Anhui Bbca Pharmaceutical Co., Ltd is a national high and new tech enterprise based in Hefei, China, operating as a manufacturer and trading company. Established as a subsidiary of BBCA Group, the company was the first pharmaceutical entity listed in Anhui province, trading on the Shenzhen Stock Exchange since 2000. With an employee base ranging from 1001 to 2000 people, Anhui Bbca Pharmaceutical specializes in the R&D, manufacturing, and sales of a comprehensive range of pharmaceutical products. The company operates 53 GMP-certified international production lines across seven pharmaceutical factories and possesses a National Pharmaceutical R&D Center. Their extensive product portfolio includes Active Pharmaceutical Ingredients (APIs) such as Paracetamol, Cefuroxime Axetil, and L-Valine, along with Medical Intermediates and various pharmaceutical preparations. These preparations encompass Pharmaceutical Tablets, Pharmaceutical Capsules, Powder For Oral, Powder For Injection, Small Volume Injection, Nutrition Infusion, Pharmaceutical Transfusion, and Transdermal Patches. They also offer Antipyretic Analgesics, Antibacterial Medicine, Cardiovascular Drugs, Gynecology Medicine, Traditional Chinese Medicine, and Personal Care Medical Supplies. Anhui Bbca Pharmaceutical provides over 300 varieties of drugs in more than ten dosage forms, covering bio-pharmaceutical, chemical pharmaceutical, and Chinese Herbal Medicine fields, all complying with international quality standards such as BP, USP, and EP. The company is also a contract manufacturer and OEM provider, with a dedicated international business company handling export, import, equipment procurement, and drug registration. The broader Anhui BBCA Group, established in the 1960s, is a mixed-ownership enterprise with state-owned shares, boasting over 10,000 employees and an annual sales revenue of nearly RMB 25 billion yuan ($3.6 billion) in 2022. The group has a global presence with factories in Thailand, Hungary, and Brazil, and sales companies in Belgium, France, and the United States.